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We recently described that brief exposure of HL60 cells to a mixture of 5-chloro-2-methyl-4-isothiazolin-3-one (CMI) and 2-methyl-4-
isothiazolin-3-one (MI) induces apoptosis at low concentrations (0.001–0.01%) and necrosis at higher concentrations (0.05–0.1%). In this study,
we show that glutathione (GSH) depletion, reactive oxygen species generation, hyperpolarization of mitochondrial transmembrane potential
(ΔΨm) and formation of protein–GSH mixed disulphides (S-glutathionylation) are early molecular events that precede the induction of cell death
by CMI/MI. When the cells exhibit common signs of apoptosis, they show activation of caspase-9, reduction of ΔΨm and, more importantly,
decreased protein S-glutathionylation. In contrast, necrosis is associated with severe mitochondrial damage and maximal protein S-
glutathionylation. CMI/MI-induced cytotoxicity is also accompanied by decreased activity of GSH-related enzymes. Pre-incubation with L-
buthionine-(S,R)-sulfoximine (BSO) clearly switches the mode of cell death from apoptosis to necrosis at 0.01% CMI/MI. Collectively, these
results demonstrate that CMI/MI alters the redox status of HL60 cells, and the extent and kinetics of GSH depletion and S-glutathionylation appear
to determine whether cells undergo apoptosis or necrosis. We hypothesize that S-glutathionylation of certain thiol groups accompanied by GSH
depletion plays a critical role in the molecular mechanism of CMI/MI cytotoxicity.
© 2006 Elsevier B.V. All rights reserved.Keywords: Apoptosis; Mitochondrial transmembrane potential; Caspases; Reactive oxygen species; S-glutathionylation; Glutathione1. Introduction
Cell death occurs by two important mechanisms, apoptosis
and necrosis. Induction of the one or the other mechanism
depends of the intensity of certain stimuli. Although apoptosis is
a protective device for the organism, any deregulation or
inappropriate induction of it may cause cell damage and disease
[1].
Various agents, including withdrawal of growth factors,
oxidative stress, cytokines and anticancer drugs, treatment with⁎ Corresponding author. Tel.: +39 0577 234906; fax: +39 0577 234903.
E-mail address: distefano@unisi.it (A. Di Stefano).
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doi:10.1016/j.bbamcr.2005.12.012chemicals, DNA-damage inducers and viral infection, can
evoke the apoptotic or necrotic programme in a dose-dependent
manner [2–9]. Although many studies have established that
some early biochemical events are important for the develop-
ment of apoptosis or necrosis, their reciprocal relationships are
still unclear. Similarly, it is unknown how different noxious
agents bypass the defence systems to produce cell death. For
example, oxidative stress has a well-recognized role in the onset
of apoptosis [10,11], but it remains unclear how small doses of
oxidants, usually sufficient to trigger the apoptotic machinery,
are able to escape from the antioxidant control exerted by GSH
and other antioxidants.
We have shown that four preservatives belonging to different
chemical classes, namely phenoxyethanol, a mixture of
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(MI), imidazolidinyl-urea and pentanediol, can induce apopto-
sis vs. necrosis in HL60 cells in vitro [9]. The mixture of
isothiazolinones (CMI/MI) was the most toxic of the four
preservatives in these cells. Moreover, using independent
biochemical indexes of apoptosis, we demonstrated that CMI/
MI at low concentrations (0.001% and 0.01%) induces
apoptotic cell death at the time interval of 3–6 h (as documented
by subdiploid DNA content and phosphatidylserine exposure)
via caspase-3 activation. In contrast the HL60 response at
higher CMI/MI concentrations (0.05% and 0.1%) was necrosis.
More recently, we confirmed in normal human keratinocytes
that apoptosis and necrosis are related to the dose of CMI/MI,
and we reported that reactive oxygen species (ROS) generation
is an early and causal step in the apoptotic response [12]. We
also reported that pre-incubation of keratinocytes with the
antioxidant N-acetilcysteine (NAC) completely prevents the
appearance of all markers of apoptosis.
Recently, it was reported that the toxic effects of methyli-
sothiazolinone on neurons are mediated by a caspase-indepen-
dent pathway [13].
Since it has been reported that CMI/MI can interact with
glutathione and with sulphydryl groups of enzymes and other
proteins [14–16], we speculate that the reaction of CMI/MI with
GSH or specific thiols within cells can perturb the normal redox
balance and shift HL60 cells into a state of oxidative stress,
which induces apoptosis or necrosis. Recent evidence suggests
that the depletion of cellular glutathione, induced by several
agents such as phenethyl isothiocyanate, is a stimulus leading to
apoptosis in different cell types [17,18]; in particular, a decrease
of GSH is closely related to apoptosis in lymphoid cells [19]. In
addition, CD95 (FAS/APO-1)-mediated apoptosis was reported
to be associated with the rapid loss by efflux of reduced
glutathione from cells [20]. In contrast, other authors have
suggested that GSH loss alone does not necessarily commit
cells to apoptosis [21,22]. If this is true, it remains to clarify
which molecular event elicited by ROS is important to induce
apoptosis.
In the present study, we used HL60 cells to investigate the
role of intracellular thiols in the induction of apoptosis vs.
necrosis after CMI/MI treatment; this cell line is very sensitive
to various stimuli, including oxidative stress and CMI/MI [9],
and is the one most commonly used in the study of apoptosis.
HL60 cells were exposed to both apoptotic and necrotic doses
of CMI/MI. Using time-course and dose–response experiments
(time range: 0–3 h; dose range: 0.001–0.1% CMI/MI), we
evaluated the production of reactive oxygen species (ROS),
changes in mitochondrial transmembrane potential (Δψm), and
the levels of GSH and cysteine reduced, oxidized and bound to
proteins by mixed disulphides.
Our results show that CMI/MI treatment alters the redox
state of HL60 cells, the extent and kinetics of which
determine the choice between the apoptotic and necrotic
modes of cell death. Flow cytometric and HPLC data show
that CMI/MI cytotoxicity is associated in a dose-dependent
manner with GSH depletion, ROS generation, altered
mitochondrial function, and formation of protein–GSHmixed disulphides, a process known as S-glutathionylation.
We hypothesize that S-glutathionylation, in addition to GSH
depletion, plays a critical role in the molecular mechanism of
CMI/MI toxicity.2. Materials and methods
2.1. Reagents
A mixture of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-
isothiazolin-3-one, in an approximate ratio of 3:1 (CMI/MI, commercially
named Kathon CG™, was obtained from Rohm and Haas (Spring House,
PA, USA). Foetal calf serum (FCS) was obtained from Gibco (Milan, Italy),
Ac-LEHD-pNA from BioSource International distributed in Italy by Prodotti
Gianni (Milan, Italy). HPLC-grade reagents were purchased from Mal-
linckrodt Baker Inc. (Phillipsburg, NJ, USA). The OmniSpher C18 reversed-
phase HPLC column (250×4 mm) was purchased from Varian (Lake Forest,
CA, USA). Monobromobimane (mBrB) was obtained from Calbiochem (La
Jolla, CA, USA). RPMI medium, 2′,7′-dichlorofluorescein diacetate (DCFH-
DA), o-phthaldialdehyde (OPT), Rhodamine 123 (Rhod123), propidium
iodide (PI), L-buthionine-(S,R)-sulfoximine (BSO), glutathione (GSH),
oxidized glutathione (GSSG), N-ethylmaleimide (NEM), dithiothreitol
(DTT) and trichloroacetic acid (TCA) were obtained from Sigma-Aldrich
Corp. (St. Louis, MO, USA). Fluorescein isothiocyanate (FITC)-labeled
AnnexinV (AnnxV) kit was obtained from Boehringer Ingelheim Biopro-
ducts (Vienna, Austria).
2.2. Cell treatment
HL60 cells were donated by Prof. Marcella Cintorino, Policlinico Le Scotte,
Siena. The cells were grown in RPMI medium supplemented with 10% foetal
calf serum (FCS), glutamine (2 mM), penicillin (100 IU/ml) and streptomycin
(100 μg/ml) at 37 °C in a humidified atmosphere containing 5% CO2.
HL60 cells between the 5th and 20th passage were treated as previously
reported [9]. The cells, at the concentration of 5×105/ml, were incubated at
37 °C in RPMI medium containing 10% FCS. After 1 h of incubation, the
cells were exposed to increasing concentrations of CMI/MI (0.001–0.1%) for
10 min. They were then washed with phosphate-buffered saline (PBS),
collected by centrifugation, resuspended in fresh medium at 1×106 cells/ml (0
time) and incubated at 37 °C for different times (1 h and 3 h). At specified
times, cells were washed and resuspended in PBS and prepared for specific
assays as reported below. Cells treated with vehicle only (PBS) served as
controls.
We chose the concentrations 0.001%, 0.01%, 0.05% and 0.1% of CMI/MI
solution as supplied by the manufacturer (respectively 0.15, 1.5, 7.5 and 15
ppm of active ingredients). In fact the maximum allowed concentration in
“rinse off” products is 0.1% of Kathon CG (sold as a dilute aqueous solution
of 1.5% of the two isothiazolinones, corresponding to 15 ppm of active
ingredients), while in “leave on” products it is 0.05% (corresponding to circa
7.5 ppm). For GSH depletion, the cells were incubated for 24 h with 500 μM
L-buthionine-(S,R)-sulfoximine (BSO) and then treated with CMI/MI as
reported above.
2.3. Flow cytometric analysis
2.3.1. Evaluation of ROS production
The formation of intracellular ROS was measured using 2′,7′-dichloro-
fluorescein diacetate (DCFH-DA). By this method, it is possible to measure the
amount of H2O2 generated by increased oxidative metabolism. Viable cells can
deacetylate DCFH-DA to 2′,7′-dichlorofluorescein, which is not fluorescent but
can react quantitatively with oxygen species within the cell to produce 2′,7′-
dichlorofluorescein (DCF), which is fluorescent and is trapped inside the cell.
The cytofluorimetric measurement of the DCF produced can provide an index of
intracellular oxidation [23]. The cells were incubated for 30 min at 37 °C with
DCFH-DA (10 μM final concentration). After incubation, the cells were washed
with PBS, resuspended in fresh medium and treated with different
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DCF fluorescence, the cells were kept in ice until analysis with a FACSCalibur
flow cytometer (Becton Dickinson, Mountain View, CA, USA) equipped with
an excitation laser line at 488 nm and Cell Quest software (Becton Dickinson).
The DCF (green fluorescence) was collected in a log scale through a 530±20
band pass filter. Monoparametric histograms of the fluorescence distribution
were plotted for the estimation of ROS production.
2.3.2. Glutathione content assay
In a first series of experiments, glutathione (GSH) content was evaluated by
flow cytometry using o-phthaldialdehyde (OPT) as described by Treumer and
Valet [24]. Briefly, the OPT method is based on reaction with both glutathione
amino and sulphydryl groups, yielding a cyclic highly fluorescent product. The
OPT-GSH fluorescent product appears in the green fluorescence channel. At
different times of incubation, 1×106 cells were resuspended in 500 μl 10 mM
HEPES N[2-hydroxyethyl]piperazine-N′-[2-ethanesulphonic acid]-buffered sa-
line pH 7.4 and OPT was added (final concentration 1 mM of a stock solution
0.1 M in dimethylformamide). After 5 min of incubation at room temperature,
the cells were immediately analysed with a FACSCalibur flow cytometer as
above. The OPT-GSH (green fluorescence) was collected in a log scale through
a 530±20 band pass filter. Monoparametric histograms of the fluorescence
distribution were plotted for the estimation of GSH content.
2.3.3. Evaluation of transmembrane potential using double staining with
Rhod123 and PI
Mitochondrial transmembrane potential was assessed by flow cytometry
uptake of the cationic lipophilic dye Rhodamine 123 (Rhod123) and propidium
iodide (PI) using a commercial product according to the method described by
Gorczyca et al. [25]. Briefly, at different times of incubation, approximately
5×105 cells for each sample were treated with 4 μl of the Rhod123 stock
solution (1 μg/ml final concentration) and incubated for 30 min at 37 °C in the
dark. The cells were then washed in PBS and resuspended in 200 μl of binding
buffer plus 10 μl of the PI stock solution (10 μg/ml final concentration). The
cells, kept in ice, were analysed with a FACSCalibur flow cytometer. The
Rhod123 (green fluorescence) and the PI (red fluorescence) were both collected
in a log scale through a 530±20 and 575±15 nm band pass filter respectively.
2.4. Assay of caspase-9 activity
At different incubation times after CMI/MI exposure, the cells were washed
in PBS and resuspended in ice-cold lysis buffer (50 mM HEPES, 1 mM DTT,
0.1 mM EDTA, 10% glycerol, 0.1% CHAPS, pH 7.4 supplemented with 5 mg/
ml leupeptin). After centrifugation at 10,000×g at 4 °C, the supernatant was used
for the assay of caspase-9 activity. The protein concentration in the lysate was
determined by the Bradford assay (26). 25 μg of cell lysate were incubated in
100 μl of assay buffer (50 mM HEPES, 10 mM DTT, 0.1 mM EDTA, 10%
glycerol, 0.1% CHAPS pH 7.4, 100 mM NaCl) containing 200 μM Ac-LEHD-
pNA in the presence or absence of the caspase-9 inhibitor 0.1 μM Ac-LEHD-
CHO. The samples were incubated at 37 °C in a microtiter plate reader for 16 h.
The enzyme-catalysed release of p-nitroaniline was monitored at 405 nm. The
conversion of the substrate was linear in time and in amount of protein.
2.5. Apoptosis assays
DNA content was analysed using PI, as previously described (12). At least
20,000 events were collected for each sample using Cell Quest software; debris
was excluded from the analysis by an appropriate morphological gate of forward
scatter vs. side scatter. Fluorescein isothiocyanate (FITC)-labeled AnnexinV
(AnnxV) binding and PI uptake were assessed by flow cytometry using a
commercial kit (Boehringer Ingelheim Bioproducts, Vienna, Austria) according
to the manufacturer's instructions.
2.6. HPLC assays of thiols, disulphides, protein–thiol mixed
disulphides
Glutathione, cysteine, cysteinylglycine and homocysteine and corres-
ponding disulphides and protein–thiol mixed disulphides reduced to thiolswith DTT, were analysed with monobromobimane (mBrB) according to
Mansoor's et al. method [27], with slight modifications as below.
2.6.1. Analysis of thiols
At different times of incubation, 200 μl of cells resuspended in PBS
(containing 1×106 cells) were precipitated with 6% (w/v) TCA (final
concentration). After centrifugation of the sample (2 min at 10,000×g), the
supernatant was neutralized under saturating conditions of solid NaHCO3 and
incubated with 1 mM monobromobimane (mBrB) (final concentration) in the
dark at room temperature for 15 min. After centrifugation (2 min at 10,000×g),
90 μl of the supernatant were acidified with 20 μl 37% HCl and injected into the
HPLC column.
2.6.2. Analysis of disulphides
200 μl of resuspended cells (containing 1×106 cells) were reacted with 50 μl
of 10 mM N-ethylmaleimide (NEM) for 5 min. After deproteinization with 6%
TCA (final concentration) and centrifugation at 10,000×g for 2 min, the NEM
excess of the supernatant was extracted with dichloromethane (0.2 ml sample+2
ml dichloromethane). 100 μl of the aqueous phase were brought to neutral pH by
the addition of solid NaHCO3 and treated with 0.5 mM DTT (final
concentration) at room temperature for 20 min. An excess of mBrB (2 mM
final concentration) was then added and the sample processed as above (see
thiols).
2.6.3. Analysis of protein–thiol mixed disulphides
The protein pellet of NEM-treated samples was washed twice with 1 ml of
1.5% (w/v) TCA to remove traces of NEM and low molecular weight
compounds in the sample. The pellet was then resuspended in 0.2 ml of 1 mM
K3EDTA. After saturation with solid NaHCO3, 5 μl of 50 mM DTTwere added
to the resuspension and the sample was maintained under continuous agitation at
room temperature for 20 min. The sample was centrifuged at 10,000×g for 2 min
and 100 μl of the supernatant were deproteinized with 40 μl of 60% (w/v) TCA.
After centrifugation, 100 μl of the supernatant were neutralized with solid
NaHCO3 up to saturation and reacted with 10 μl of 40 mM mBrB. After 15 min
incubation at room temperature in the dark, the sample was acidified with HCl as
above.
Samples were injected into the HPLC column. Solvent A was 0.25% (v/v)
acetic acid, adjusted to pH 3.09 with 1N NaOH, and solvent B was methanol.
The elution profile was as follows: 0–8 min, 20% B; 8–15 min, 20–40% B; 15–
25 min, 40–100% B. A constant flow rate of 1.0 ml/min was applied. HPLC
separation was performed with a Hewlett-Packard 1100 series apparatus,
equipped with fluorescence detection (excitation, 380 nm; emission 480 nm).
The retention times for cysteine, cysteinylglycine, homocysteine and glutathione
were 6.0, 6.7, 10.1 and 12.2, respectively.
Appropriate concentrations of glutathione, cysteine, cysteinylglycine,
homocysteine and corresponding disulphides were used to prepare calibration
curves in PBS or in PBS+DTT, respectively. The calibration curves were linear
from 0.3 μM to 100 μM (3.2 pmol/injection to 1073 pmol/injection). The
detection limit was 2 pmol/injection (injection volume 0.02 ml).
2.7. Enzyme activities
Cells collected by centrifugation, washed twice in PBS and resuspended
at 5×106 cells/ml in 20 mM Tris–HCl with 0.5 mM K3EDTA pH 7.6, were
lysed by three cycles of freezing (−80 °C) and thawing. After centrifugation
at 10,000×g for 2 min at 4 °C, the activities of glucose-6-phosphate
dehydrogenase (G-6-PDH), glutathione reductase (GR), glutathione transfer-
ase (GST) and glutathione peroxidase (GPX) in the supernatants were assayed
spectrophotometrically at 37 °C using a JASCO UV-VIS 550 spectropho-
tometer. G-6-PDH was detected by modification of the methods described by
Glock and McLean [28]. Briefly, the sample was added to a cuvette
containing 1 mM NADP+ and 1 mM G-6-P in 0.1 mM Tris–HCl pH 7.6, and
the reaction was followed at 340 nm for 5 min. The reaction rate was
calculated in the last 2 min (3 min time lag). GR was assayed by the method
of Calberg and Mannervik [29], while GST was assayed by the method of
Habig et al. using 1-chloro-2,4-dinitrobenzene as substrate [30]. GPX was
assayed by the method of Wendel using cumene hydroperoxide as substrate
[31].
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according to the Bradford method [26].
2.8. Statistics
The results are presented as means±S.D. from at least three-six independent
experiments. Student's t-test was used to assess the significance of differences
between the treatment and control groups. Moreover, the same test was used in
time-course experiments of glutathione to evaluate the significance of the
differences between each incubation time and 0 time.3. Results
CMI/MI induces ROS generation, GSH depletion and
changes in Δψm.
ROS production (Fig. 1), GSH content (Fig. 2) and
mitochondrial changes (Fig. 3) were monitored by flow cyto-Fig. 1. Flow cytometric analysis of the time-course of ROS generation in HL60 cells e
with DCFH-DA, then washed and resuspended in fresh medium and treated with incr
medium and incubated at 37 °C. At the indicated times after treatment, the fluorescenc
independent experiments. Filled histograms correspond to control cells while open his
intensity; the y-axis indicates the cell number. ROS production was quantified as thmetry in the time interval 0–3 h at increasing CMI/MI doses
(0.001–0.1%).
3.1. ROS production
The conversion of DCFH-DA to fluorescent DCF by H2O2
was used to monitor ROS production. As shown in Fig. 1, all
concentrations of CMI/MI caused an increase of intracellular
ROS accumulation starting as early as 0 time after treatment.
The cell percentage with increased ROS production at the
maximum doses was relatively high and remained rather
constant within 30 min of monitoring (N60% of cells with
high ROS production). Thereafter, a further marked increase of
cell percentage with increased ROS generation occurred at
0.05% and 0.1% CMI/MI and remained high until 3 h after
treatment. At the intermediate dose (0.01%), ROS productionxposed to increasing concentrations of CMI/MI. Cells were incubated for 30 min
easing concentrations of CMI/MI (0.001–0.1%) for 10 min, resuspended in fresh
e intensity was determined by flow cytometry. Similar data were obtained in four
tograms represent CMI/MI-treated cells. The x-axis shows log FL-1 fluorescence
e percentage of cells with increased fluorescence relative to control.
Fig. 2. Flow cytometric analysis of the time-course of GSH content in HL60 cells exposed to increasing concentrations of CMI/MI. Cells were incubated with
increasing concentrations of CMI/MI (0.001–0.1%) for 10 min, resuspended in fresh medium and incubated at 37 °C. At the indicated times, untreated and CMI/MI-
treated HL60 cells were loaded for 5 min with OPT and the fluorescence intensity was determined by flow cytometry. These experiments were performed three times
with very similar results. Filled histograms correspond to control cells, while open histograms represent CMI/MI-treated cells. The x-axis shows log FL-1 fluorescence
intensity; the y-axis indicates the cell number. Decreased fluorescence (highlighted by the marker) indicates reduction of GSH content.
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observation times.
At the lowest CMI/MI dose (0.001%), signs of oxidative
stress were immediately observed in about 32% of cells. These
signs were relatively constant for 30 min, then dropped to about
20% at 1 h and to about 15% by the end of the experiment.
Interestingly, there was a clear gap in ROS production between
0.001% and 0.01% CMI/MI at all times.
3.2. GSH changes
We monitored GSH changes in HL60 cells exposed to CMI/
MI via the decrease in OPT fluorescence (Fig. 2). CMI/MI
treatment at high concentrations (0.01–0.1%) triggered a rapid
decrease of intracellular GSH as early as 0 h. GSH levels tendedto recover within 15–30 min, but there was another dramatic
GSH decrease between 1 and 3 h. The lowest CMI/MI dose
(0.001%) caused a small non-significant decrease in glutathione
within 15 min as well as a non-significant GSH recovery over
time (9% of depleted cells at 30 min and 10% at 60 min).
To prove the relationship between the extent of GSH
depletion and the severity of CMI/MI toxicity, the cells were
pre-incubated for 24 h with 500 μM BSO, which was
maintained during the treatment with CMI/MI at different
concentrations. Table 1 reports the induction of apoptosis and
necrosis in HL60 cells exposed to CMI/MI with and without
pre-incubation with BSO.
Cells depleted of GSH (BSO decreased GSH content, as
evaluated by monobromobimane, from 55.8±2.3 nmol mg−1
proteins to 14.0±2.9 nmol mg−1 proteins) were vital and did not
Fig. 3. Flow cytometric analysis of the time-course of mitochondrial transmembrane potential in HL60 cells exposed to increasing concentrations of CMI/MI. At the indicated times, untreated and CMI/MI-treated HL60
cells were loaded for 30 min with Rhod123 and the fluorescence intensity was determined by flow cytometry. (A) Results of a typical experiment where filled histograms correspond to control cells, while open
histograms represent CMI/MI-treated cells. The x-axis shows log FL-1 fluorescence intensity; the y-axis indicates the cell number. Increased or decreased fluorescence (highlighted by the markers) indicates increase or
reduction of mitochondrial transmembrane potential (Δψm). Panels B and C report the percentages±S.D. (n=4) of cells with increased or decreased fluorescence, respectively. *Statistically significant with respect to
control Pb0.05 (Student's t-test).
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Table 1
Induction of apoptosis and necrosis in HL60 cells exposed to increasing
concentrations of CMI/MI with and without preincubation with BSO
CMI/MI
concentration
Apoptosis Sub-G1 (%) AnnxV-
positive and
PI-negative
cells (%)
AnnxV-
positive and
PI-positive
cells (%)
Time after
exposure
3 h 6 h 3 h 3 h
– +BSO – +BSO – +BSO – +BSO
CTR 0.24 0.50 0.68 0.73 1.3 0.46 1.5 1.46
0.001% 5.48 8.30 9.05 15.06 12.37 20.91 1.54 3.2
0.01% 19.51 1.60 37.71 8.67 8.59 1.04 33.69 79.65
0.05% 1.73 1.05 2.41 1.20 2.15 0.13 94.01 95.20
0.1% 1.23 1.13 1.33 1.01 1.17 0.20 98.56 99.13
Cells were incubated for 24 h with and without BSO 500 μM and treated with
CMI/MI (0.001–0.1%) for 10 min, resuspended in fresh medium and incubated
at 37 °C for 3 and 6 h. The induction of apoptosis, evaluated by flow cytometry,
is reported as the percentage of cells showing subdiploid DNA content (Sub-
G1), the percentage of annexin V (AnnxV)-positive and propidium iodide (PI)-
negative cells (early apoptotic cells), and the percentage of AnnxV-positive and
PI-positive cells (late apoptotic/necrotic cells). Values are the average of five
separate experiments.
Fig. 4. Time-course of caspase-9 activity in HL60 cells treated with increasing
concentrations of CMI/MI. Lysates (25 μg) made from CMI/MI-treated HL60
cells at different times after treatment were incubated in 100 μl of assay buffer
containing the specific Tetrapeptide substrate, Ac-LEHD-pNA (200 μM).
Caspase activity is expressed as the O.D. 405 nm value±S.D. (n=3).
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concentrations exhibited an increase in both the cellular content
of subdiploid DNA and externalization of phosphatidylserine
(AnnxV-positive and propidium iodide-negative). However, in
cells pre-incubated with BSO, both these markers of apoptosis
were increased after treatment with 0.001% CMI/MI and were
decreased or absent after 0.01% CMI/MI. Moreover, after
treatment with BSO and 0.01% CMI/MI, the percentage of
AnnxV-positive and PI-positive cells was increased, indicating
loss of plasma membrane integrity, as occurred at necrotic doses
of CMI/MI.
3.3. ΔΨm changes
We examined changes in Δψm in CMI/MI-treated HL60
cells to clarify the role of mitochondria, since mitochondrial
functionality is a crucial factor in cytotoxic processes leading to
apoptosis. Using Rhod123, a cationic lipophilic dye readily
incorporated into mitochondria in a manner dependent on
mitochondrial transmembrane potential (Δψm), we were able to
evaluate mitochondrial changes in HL60 cells from 0 to 3 h after
CMI/MI treatment.
Untreated cells and cells treated with CMI/MI were loaded
with Rhod123. The fluorescence intensity was then analysed
by flow cytometry and plotted as a fluorescence histogram.
Fig. 3A illustrates the time-course of changes in ΔΨm after
CMI/MI treatment. After 10 min of exposure to CMI/MI, a
subpopulation of cells gained green fluorescence (consistent
with higher ΔΨm) as early as 0 time and increased over time
until 30 min after treatment at all doses (Fig. 3A and B).
Then, the percentage of hyperpolarized cells decreased at
1 h (Fig. 3A and B). At the same time (1 h), about 17%, 49%
and 60% of cells, treated respectively with 0.01%, 0.05% and
0.1% CMI/MI, showed significantly decreased ΔΨm with
respect to control (Fig. 3A and C). At the lowest CMI/MI dose(0.001%), the percentage of hyperpolarized cells returned to
control levels at 1 h after treatment (Fig. 3A and B), while cells
with reduced Δψm appeared only after 3 h (Fig. 3A and C). At
0.05% and 0.1% CMI/MI, nearly all cells (95%) showed a loss
of Δψm at 3 h.
3.4. CMI/MI induces caspase-9 activation and apoptosis
The well-documented disruption of Δψm prompted us to
evaluate activation by CMI/MI of caspase-9, an apical enzyme
in the mitochondrial pathway of apoptosis [32]. We reported
previously [9] that a caspase-3-like increase was most evident 3
h after a 10-min exposure to CMI/MI, and that this was the time
at which the marker of apoptosis appeared. Therefore, we
decided to evaluate caspase-9 (a caspase located upstream of
caspase-3 in the caspase signalling cascade) at 1.5 h and 3 h, as
these should have been the most appropriate times to record
increased caspase-9 activity. In effect, Fig. 4 shows that
caspase-9 was activated in a dose-dependent manner at
apoptotic doses of CMI/MI (0.001% and 0.01%). In particular,
maximal activation was observed at 3 h at 0.01%, whereas no
activation was obtained at any time at necrotic doses (0.05%
and 0.1%, data not shown). The activation of caspase-9 at
apoptotic concentrations was completely blocked by addition of
the caspase-9 inhibitor Ac-LEHD-CHO to the mixture (data not
shown).
3.5. Changes of thiols and S-glutathionylation of proteins
induced by CMI/MI
To confirm the GSH depletion over time seen in Fig. 2 and to
better clarify the mechanism of CMI/MI cell metabolism, we
studied changes of GSH and other thiols, such as cysteine,
homocysteine and cysteinylglycine, and corresponding disul-
phides and protein–thiol mixed disulphides via HPLC.
However, only glutathione and cysteine were detectable in
our experimental conditions.
Fig. 5. Time-courses of GSH, GSSG and GSSP in HL60 cells treated with
0.001–0.1% CMI/MI. GSH (A); GSSG (B); GSSP (C) were determined by
HPLC after mBrB derivatization (see Materials and methods). The values are
expressed as mean±S.D. nmol mg−1 proteins (n=6). *Statistically significant
with respect to control Pb0.05 (Student's t-test). **Statistically significant with
respect to control Pb0.001 (Student's t-test), §statistically significant with
respect to 0 time Pb0.05 (Student's t-test).
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Dose-related GSH depletion was observed at all times (Fig.
5A), confirming previous results obtained at the cytofluori-
meter. After the immediate depletion at 0 h, only 0.001% CMI/
MI-treated cells showed a recovery to the control GSH levels at
1 h and 3 h, with a significant increase compared with 0 time,
whereas at the other doses (0.01%, 0.05%, 0.1%) the cells did
not show a recovery to their control GSH levels even if there
was a significant increase (in some cases) with respect to 0 time.
In contrast to the remarkable GSH depletion, cysteine did not
change over time (control value: 3.62±1.89 nmol mg−1
proteins; data not shown).
3.5.2. Disulphides and protein–thiol mixed disulphides
There was no significant oxidized glutathione (GSSG)
change with respect to control, except at the highest CMI/MI
doses (0.05%–0.1%), i.e. at 3 h the levels were significantly
decreased with respect to 0 h (Fig. 5B).
The glutathione–protein mixed disulphide (GSSP) data (Fig.
5C) indicated a strong oxidant action by CMI/MI, except at the
lowest CMI/MI dose (0.001%). In fact, there was a large gap
between 0.001% and the higher CMI/MI doses. In particular,
the GSSP increase was very high at 0 time at 0.01%, 0.05% and
0.1% CMI/MI and then decreased significantly at 3 h with
respect to 0 h. However, the GSSP decrease over time was
higher at 0.01% CMI/MI and the GSSP levels peaked earlier (0
h) than at the other doses.
Cystine and cysteine–protein mixed disulphides (cystine
control value: 21.1±7.4 nmol/mg of proteins; cysteine–protein
mixed disulphide control value: 1.32±0.84 nmol/mg of
proteins; n=4) did not vary significantly with respect to control
(data not shown).
3.6. The antioxidant response of GSH-related enzymes
to CMI/MI
We decided to investigate the role played by various
glutathione-dependent enzymes (G-6-PDH, GR, GPX, GST)
that have great importance to regulate the intracellular redox
state of GSH and whose activity has been related, to some
extent, to the presence of available protein SH groups (PSH)
[33–35]. Although GPX activity (data not shown) did not
change with respect to control, the activities of G-6-PDH, GR
and GST decreased in a dose-dependent manner at all times
(Fig. 6). The most susceptible enzyme was GR whose activity
dropped to about 60% of control at the lowest CMI/MI dose
(0.001%) at 0 time.
4. Discussion
Isothiazolinone (or isothiazolone)-derived compounds, such
as Kathon CG (a 3:1 mixture of CMI and MI), are used for
various purposes as preservatives and biocides [36]. However,
Kathon CG may cause occupational diseases such as dermatitis
and allergic sensitization [37]. CMI is considered a strong
sensitizer, while MI is a weak sensitizer. In spite of these
electrophilic differences, evaluated in reactions with amino
Fig. 6. Activity of G-6-PDH, GR, GST in HL60 cells treated with 0.001%–0.1%
CMI/MI. Mean values are expressed as percentage of activity (nmol min−1 mg−1
proteins). The control activities were: G-6-PDH 311±41 nmol min−1 mg−1
proteins; GR 184±6 nmol min−1 mg−1 proteins; GST 236±34 nmol min−1 mg−1
proteins, of three independent experiments whose standard deviation (omitted
for clarity) did not exceed 15% of the mean.
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with thiols, the most potent nucleophiles [15], and thus can be
considered strong GSH depletors in cells. For example,
although MI is less reactive than CMI, it can easily attack
GSH, as recently demonstrated in cultured neurons [13]. In
theory, CMI/MI can also attack exposed PSH, but this action
should be prevented by the relatively high GSH concentration in
cells.
We reported previously that CMI/MI at low concentrations
(0.001% and 0.01%) induced apoptotic death in HL60 cells (as
documented by subdiploid DNA content and phosphatidylser-
ine exposure) via caspase-3, while at higher concentrations
(0.05% and 0.1%) the response was necrosis [9]. More recently,
we reported that CMI/MI also causes apoptosis and oxidative
stress in human keratinocytes [12].
The aims of the present experiments on HL60 cells, an
appropriate model of apoptosis, were to clarify the mechanism
of CMI/MI toxicity towards thiols and to evaluate whether
CMI/MI induces GSH depletion by oxidative stress, an event
that is considered important for activation of cells to apoptosis
and necrosis [19]. The results show that the cytotoxicity of
CMI/MI in HL60 cells is associated with ROS generation (Fig.
1), GSH depletion (Fig. 2) and changes in mitochondrial
transmembrane potential (Fig. 3). All these biochemical
perturbations are much greater during necrosis than during
apoptosis. Brief incubation (10 min) of HL60 with CMI/MI was
able to trigger a dose-dependent increase in cellular oxidation
states as early as 0 min. At the lowest CMI/MI concentration
(0.001%), the ROS increase, more pronounced at 0 time, was
not accompanied by GSH depletion (Fig. 2). Conversely, at the
highest CMI/MI doses, GSH was depleted rather suddenly and
this was matched by abundant ROS production, so it was
difficult to discern whether the intracellular ROS production
preceded the drop in GSH levels or vice versa. Therefore, it is
not clear whether the GSH depletion is the cause or the result of
ROS generation.
Having re-examined the role of GSH in subsequent
experiments to clarify whether the GSH depletion by CMI/MI
was due to GSH-conjugation or GSSG formation, we confirmed
that there was no GSH depletion at the lowest CMI/MI dose
(0.001%) and strong GSH depletion at the higher doses (0.01%,
0.05% and 0.1%) (Fig. 5A). Only a fraction of the GSH lost at
all CMI/MI concentrations was converted to GSSG, suggesting
that other mechanisms are involved in the GSH depletion. It has
been reported that cells undergoing apoptosis exhibit increased
GSSG levels [38] or alternatively export GSH into the
extracellular space [39]. We evaluated GSH in the cell culture
medium at all times after CMI/MI exposure but the GSH level
remained constant during the experiments (data not shown),
suggesting that the loss of GSH was probably not due to an
efflux of GSH. As both CMI and MI were found to react very
rapidly with GSH [15], we cannot rule out the possibility that a
direct reaction between GSH and CMI/MI occurred in our
experimental conditions, with the formation of a GSH-
conjugate [15]. This suggestion is confirmed by the fact that
total GSH (sum of GSH, GSSG and GSSP) was always lower
than the respective control at each time at 0.01%, 0.05% and
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h, 1 h, 3 h: 36%, 25%, 20%, respectively; total GSH depletion at
0.1% CMI/MI at 0 h, 1 h, 3 h: 60%, 56%, 67%, respectively),
but not at the lowest dose (0.001%) where total GSH was equal
to or higher than control (data not shown). Therefore, we
suggest that part of the GSH was consumed for the formation of
GSH-CMI/MI adducts.
It has been reported that a loss of GSH sensitizes cells to the
induction of apoptosis, while a loss of GSH is not sufficient
itself to initiate apoptosis [21,22,39,40]. We also observed that
pre-treatment for 24 h with BSO, a selective inhibitor of
gamma-glutamylcysteine synthetase, does not cause apoptosis
in HL60 cells despite a marked decrease of cellular glutathione;
instead, it clearly switches the mode of cell death from apoptosis
to necrosis at 0.01% CMI/MI.
Mitochondria play an essential role in many types of
apoptotic death, releasing cytochrome c, which triggers a
cascade of caspase activation events. Consistent with these
observations, CMI/MI caused at all doses an early increase of
Δψm, an event associated with several apoptotic pathways [41–
43] while at longer times the mitochondrial transmembrane
potential collapsed; simultaneously the activation of caspase-9
occurred only at CMI/MI concentrations (Fig. 4) previously
always found to be clearly apoptotic [9]. These results show that
alterations of mitochondrial function accompany CMI/MI-
induced cytotoxicity, as supported by the MTT assay (which
is dependent on mitochondrial redox reactions) [9].
S-glutathionylation, through the formation of a mixed
disulphide between a protein SH residue and glutathione, is
an antioxidant device that reduces the impact of an oxidative
stressor but at the same time modulates protein activity if critical
PSH are involved, as for example during cell proliferation,
apoptosis and differentiation [44–46]. We observed a dose-
dependent increase in GSSP at all times (Fig. 5C), except at the
lowest CMI/MI dose (0.001%). Low levels of S-glutathionyla-
tion (generally rapidly reversible) appear to be associated with
the apoptotic response (see the protein glutathionylation trend at
0.01% CMI/MI in Fig. 5), while high and sustained levels are
associated with necrosis.
According to the literature [14,15], the high reactivity of
CMI/MI towards thiols may be due to a variety of reaction
mechanisms and end-products. We assume that the lipophilic
character of CMI/MI causes it to react preferentially with PSH
rather than with GSH, opening the ring of the CMI/MI structure
and forming a mixed disulphide (CMI/MI–protein). In turn,
CMI/MI–protein mixed disulphides would generate GSSP at 0
time by a thiol/disulphide exchange reaction with GSH,
delivering CMI/MI-SH derivatives (thioacyl chloride) [15].
However, other more complex mechanisms inside the cells
could also yield GSSP as end-products [15].
The low or absent protein glutathionylation in control cells
and in those exposed to the lowest CMI/MI concentration was
considered indirect evidence that these cells efficiently control
their intracellular redox state by GR and G-6-PDH activities
[33–35]. Despite this, the enzymatic activities of GR, G-6-
PDH and GST were highly sensitive to CMI/MI, being very
rapidly depressed after exposure to all CMI/MI doses (Fig. 6),whereas GPX was unchanged (data not shown) (GPX control
value: 552±53 nmol min−1 mg−1 protein; n=3). In particular,
the inhibition of GR and G-6-PDH, potent regulators of GSSG
and GSSP levels [33–35], may explain the high protein S-
glutathionylation, which at 0 time increased more than 40 fold
with respect to control after 0.01% CMI/MI exposure (Fig. 5).
At the lowest CMI/MI concentration (0.001%), these enzymes
were depressed (Fig. 6) but still sufficiently active to control
the GSSP production. The lack of GPX changes is interpreted
as the cell's necessity to eliminate excessive ROS production
(H2O2).
Cysteine-rich membrane receptors, such as Fas antigen (a
member of the tumour necrosis factor receptor family), and
caspases can be included in the proteins involved in triggering
apoptosis that might be regulated by changes in redox status.
We investigated if CMI/MI treatment changes the expression of
Fas, which is constitutively expressed by HL60 cells. We failed
to detect changes in Fas expression at any time after treatment
(data not shown); in contrast, increased Fas expression was
detected in human keratinocytes treated with 0.01% CMI/MI
[12], suggesting that Fas/FasL-mediated apoptosis plays a role
in the widely described allergic contact dermatitis reactions to
CMI/MI [47].
Caspases (cysteine proteinases implicated as mediators of
apoptosis) contain critical thiol groups and are regulated by
changes in redox status [48]. At 0.01% CMI/MI, the maximum
activity of caspase-9 and caspase-3 [9] occurred at 3 h when the
cells barely showed signs of apoptosis (Table 1) and protein
glutathionylation was decreased about 10 fold with respect to
the value at 0 time (Fig. 5C). Since GSSG and disulfiram inhibit
caspase-3 activity via the formation of protein–thiol mixed
disulphides [49], we speculate that phenomena of thiolation/
dethiolation of caspases might be associated with their
activation. No caspase activity was recorded at higher CMI/
MI doses (inducing higher levels of protein glutathionylation),
suggesting that inhibition of caspase activity (possibly through
S-glutathionylation) prevents the appearance of features typical
of apoptosis and that the cells are committed to death by
necrosis. Therefore, the possibility of caspase glutathionylation
is an important issue that deserves further studies to clarify the
relationships with activation of the cell death programme.
The lack of a decrease in cysteine levels after CMI/MI
exposure cannot easily be explained; in fact, similar to what was
observed for glutathione, cysteine depletion was expected
because of the high reactivity of CMI/MI with thiols [14].
Therefore, it is unclear why CMI/MI exposure depleted total
GSH but not total cysteine.
The picture that emerges from the study of the relationship
between CMI/MI cytotoxicity and thiols is that CMI/MI very
rapidly perturbs the normal redox balance and shifts HL60 cells
into a state of oxidative stress. Given the high reactivity of CMI/
MI, GSH or critical PSH can be attacked, opening the CMI/MI
structure by cleavage of the S\N bond and forming a protein–
thiol mixed disulphide (or a mixed disulphide), which in turn
generates GSSP by thiol/disulphide exchange reactions. The
extent and kinetics of GSH depletion and S-glutathionylation
appear to determine whether cells undergo apoptosis or
224 A. Di Stefano et al. / Biochimica et Biophysica Acta 1763 (2006) 214–225necrosis. We hypothesize that S-glutathionylation of certain
thiol groups accompanied by GSH depletion plays a critical role
in the molecular mechanism of CMI/MI.
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